Cargando…
Pervasive inflammatory activation in patients with deficiency in very‐long‐chain acyl‐coA dehydrogenase (VLCADD)
OBJECTIVES: Very‐long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) is a disorder of fatty acid oxidation. Symptoms are managed by dietary supplementation with medium‐chain fatty acids that bypass the metabolic block. However, patients remain vulnerable to hospitalisations because of rhabdomyolys...
Autores principales: | Vallejo, Abbe N, Mroczkowski, Henry J, Michel, Joshua J, Woolford, Michael, Blair, Harry C, Griffin, Patricia, McCracken, Elizabeth, Mihalik, Stephanie J, Reyes‐Mugica, Miguel, Vockley, Jerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236555/ https://www.ncbi.nlm.nih.gov/pubmed/34194748 http://dx.doi.org/10.1002/cti2.1304 |
Ejemplares similares
-
Fasting induces prominent proteomic changes in liver in very long chain Acyl-CoA dehydrogenase deficient mice
por: Wang, Wei, et al.
Publicado: (2016) -
Medium chain acyl-CoA dehydrogenase deficiency in a premature infant
por: Dobrowolski, Steven F., et al.
Publicado: (2017) -
Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Gene-Targeted Mice
por: Tolwani, Ravi J, et al.
Publicado: (2005) -
A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns
por: Sebaa, Rajaa, et al.
Publicado: (2023) -
Cardiac Hypertrophy in Mice with Long-Chain Acyl-CoA Dehydrogenase (LCAD) or Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
por: Cox, Keith B., et al.
Publicado: (2009)